Flexible lid to the p53-binding domain of human Mdm2: Implications for p53 regulation

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2003-01-27

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1073/pnas.0334477100PMID 12552135PMCID PMC149886
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of the Accumulation and Function of p53 by Phosphorylation of Two Residues within the Domain That Binds to Mdm2*

  2002cited by this paper
• Mutation of Mouse p53 Ser23 and the Response to DNA Damage

  2002cited by this paper
• A p53 Amino-Terminal Nuclear Export Signal Inhibited by DNA Damage-Induced Phosphorylation

  2001cited by this paper
• Critical roles for the serine 20, but not the serine 15, phosphorylation site and for the polyproline domain in regulating p53 turnover.

  2001cited by this paper
• Development of a binding assay for p53/HDM2 by using homogeneous time-resolved fluorescence.

  2000cited by this paper
• DNA damage-induced activation of p53 by the checkpoint kinase Chk2.

  2000cited by this paper
• ATM complexes with HDM2 and promotes its rapid phosphorylation in a p53-independent manner in normal and tumor human cells exposed to ionizing radiation

  2000cited by this paper
• Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53.

  2000cited by this paper
• Thermodynamics of p53 binding to hdm2(1-126): effects of phosphorylation and p53 peptide length.

  2000cited by this paper
• Multiple sites of in vivo phosphorylation in the MDM2 oncoprotein cluster within two important functional domains

  2000cited by this paper
• Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2

  1999cited by this paper
• Regulation of the p53 Tumor Suppressor Protein*

  1999cited by this paper
• DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation

  1999cited by this paper
• Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage.

  1999cited by this paper
• Phosphorylation of p53 protein in response to ionizing radiation occurs at multiple sites in both normal and DNA-PK deficient cells

  1999cited by this paper
• DNA damage‐inducible phosphorylation of p53 at N‐terminal sites including a novel site, Ser20, requires tetramerization

  1999cited by this paper
• Mutations in serines 15 and 20 of human p53 impair its apoptotic activity

  1999cited by this paper
• p53 regulation by post-translational modification and nuclear retention in response to diverse stresses

  1999cited by this paper
• Comparative study of the p53-mdm2 and p53-MDMX interfaces

  1999cited by this paper
• Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage.

  1999cited by this paper
• Regulation of p53 Function and Stability by Phosphorylation

  1999cited by this paper
• Nuclear Export Is Required for Degradation of Endogenous p53 by MDM2 and Human Papillomavirus E6

  1998cited by this paper
• Enhanced phosphorylation of p53 by ATM in response to DNA damage.

  1998cited by this paper
• Nucleo‐cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein

  1998cited by this paper
• Mdm2 association with p53 targets its ubiquitination

  1998cited by this paper
• Activation of the ATM kinase by ionizing radiation and phosphorylation of p53.

  1998cited by this paper
• p53, the Cellular Gatekeeper Review for Growth and Division

  1997cited by this paper
• Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53

  1997cited by this paper
• DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2.

  1997cited by this paper
• Mdm-2 phosphorylation by DNA-dependent protein kinase prevents interaction with p53.

  1997cited by this paper
• Mdm2 promotes the rapid degradation of p53

  1997cited by this paper
• Regulation of p53 stability by Mdm2

  1997cited by this paper
• Discovering High-Affinity Ligands for Proteins: SAR by NMR

  1996cited by this paper
• Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain

  1996cited by this paper
• The 13C Chemical-Shift Index: A simple method for the identification of protein secondary structure using 13C chemical-shift data

  1994cited by this paper
• Methodological advances in protein NMR

  1993cited by this paper
• Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53

  1993cited by this paper
• The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

  1992cited by this paper
• Lipases reach the surface

  1991cited by this paper
• A model for interfacial activation in lipases from the structure of a fungal lipase-inhibitor complex

  1991cited by this paper
• Enzymology. Lipases reach the surface.

  1991cited by this paper
• Effector domains of human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex are functionally interchangeable and share an essential peptide motif

  1991cited by this paper

• Mechanistic Role of the Mdm2/MdmX Lid Domain in Regulating Their Interactions with p53

  2025cites this paper
• Citrullination at the N‐terminal region of MDM2 by the PADI4 enzyme

  2025cites this paper
• Structural adaptation of secondary p53 binding sites on MDM2 and MDMX.

  2024cites this paper
• Deciphering the Multi-state Conformational Equilibrium of HDM2 in the Regulation of p53 Binding: Perspectives from Molecular Dynamics Simulation and NMR Analysis.

  2024cites this paper
• Conformational Stability of the N-Terminal Region of MDM2

  2023cites this paper
• New insights into cancer: MDM2 binds to the citrullinating enzyme PADI4

  2023influential citation
• Targeting Mouse Double Minute 2: Current Concepts in DNA Damage Repair and Therapeutic Approaches in Cancer

  2020cites this paper
• p53 Phosphomimetics Preserve Transient Secondary Structure but Reduce Binding to Mdm2 and MdmX

  2019cites this paper
• The C-terminal SAM domain of p73 binds to the N terminus of MDM2.

  2019cites this paper
• Hitting on the move: Targeting intrinsically disordered protein states of the MDM2-p53 interaction.

  2019cites this paper
• Cancer II

  2018cites this paper
• Mathematical Modeling Identification of Active Sites Interaction of Protein Molecules

  2018cites this paper
• Inhibiting mechanism of small molecule toward the p53‐MDM2 interaction: A molecular dynamic exploration

  2018cites this paper
• Binding Kinetics of the Intrinsically Disordered p53 Family Transactivation Domains and MDM2.

  2018cites this paper
• Title In vitro selection of mutant HDM 2 resistant to nutlininhibition

  2017cites this paper
• Explorer Chemical states of the N-terminal " lid " of MDM 2 regulate p 53 binding Simulations reveal complexities of modulation

  2017cites this paper
• Structural effects and competition mechanisms targeting the interactions between p53 and MDM2 for cancer therapy

  2017cites this paper
• The Mechanism of p53 Rescue by SUSP4.

  2017cites this paper
• Role of the N-terminal lid in regulating the interaction of phosphorylated MDMX with p53

  2017cites this paper
• Title Binding of translationally controlled tumour protein to theN-terminal domain of HDM 2 is inhibited by Nutlin-3

  2017cites this paper
• Protein-protein interaction inhibitors

  2017cites this paper
• LC-MS/MS-based targeted proteomics quantitatively detects the interaction between p53 and MDM2 in breast cancer.

  2017cites this paper
• Mechanism of Competition between Nutlin3 and p53 for Binding with Mdm2

  2017cites this paper
• Efficient Atomistic Simulation of Pathways and Calculation of Rate Constants for a Protein-Peptide Binding Process: Application to the MDM2 Protein and an Intrinsically Disordered p53 Peptide.

  2016cites this paper
• Functional Interrogation of the N-Terminal Lid of MDMX in p53 Binding via Native Chemical Ligation.

  2016cites this paper
• Structural basis of how stress-induced MDMX phosphorylation activates p53

  2016cites this paper
• The E3 ubiquitin protein ligase MDM2 dictates all-trans retinoic acid-induced osteoblastic differentiation of osteosarcoma cells by modulating the degradation of RARα

  2016cites this paper
• MDMX (MDM4), a Promising Target for p53 Reactivation Therapy and Beyond.

  2016cites this paper
• Protein-peptide molecular docking with large-scale conformational changes: the p53-MDM2 interaction

  2016cites this paper
• Impact of Ser17 Phosphorylation on the Conformational Dynamics of the Oncoprotein MDM2.

  2016cites this paper
• Structural convergence of unstructured p53 family transactivation domains in MDM2 recognition

  2015cites this paper
• Elucidation of Ligand-Dependent Modulation of Disorder-Order Transitions in the Oncoprotein MDM2

  2015cites this paper
• Phosphomimetic mutation of the N-terminal lid of MDM2 enhances the polyubiquitination of p53 through stimulation of E2-ubiquitin thioester hydrolysis.

  2015cites this paper
• Escape, or Vanish: Control the Fate of p53 through MDM2-Mediated Ubiquitination.

  2015cites this paper
• Role of the RING domain in MDM2-mediated ubiquitination of p53

  2015cites this paper
• The Design Development of Small Molecule Inhibitors Targeting Unregulated Transcription Factors in Acute Myeloid Leukemia

  2015cites this paper
• Microsecond simulations of mdm2 and its complex with p53 yield insight into force field accuracy and conformational dynamics

  2015cites this paper
• Mechanism of Stapled Peptide Binding to MDM2: Possible Consequences for Peptide Design.

  2014cites this paper
• Targeting the MDM2–p53 Protein–Protein Interaction: Design, Discovery, and Development of Novel Anticancer Agents

  2014cites this paper
• Inhibition of protein-peptide interactions by small molecules

  2014cites this paper
• A systems wide mass spectrometric based linear motif screen to identify dominant in-vivo interacting proteins for the ubiquitin ligase MDM2.

  2014cites this paper
• In Vitro Selection of Mutant HDM2 Resistant to Nutlin Inhibition

  2013cites this paper
• Functional Diversity and Structural Disorder in the Human Ubiquitination Pathway

  2013cites this paper
• Efficient Computer Simulations of Protein-Peptide Binding Using Weighted Ensemble Sampling

  2013cites this paper
• Transient protein states in designing inhibitors of the MDM2-p53 interaction.

  2013cites this paper
• Investigating pathways in tumour cell migration and invasion in response to novel isoquinolinone compounds

  2013cites this paper
• Identification of a second Nutlin‐3 responsive interaction site in the N‐terminal domain of MDM2 using hydrogen/deuterium exchange mass spectrometry

  2013influential citation
• Molecular Modelling Studies on Molecular Pathways Related to Tumorigenesis in the Discovery of New Lead Compounds.

  2012cites this paper
• Ordering of the N-terminus of human MDM2 by small molecule inhibitors.

  2012cites this paper
• Atomistic Insights Into the Regulatory Mechanisms Mediated by Post- Translational Modifications: Molecular Dynamics Investigations

  2012cites this paper
• Interrogation of MDM2 phosphorylation in p53 activation using native chemical ligation: the functional role of Ser17 phosphorylation in MDM2 reexamined.

  2012cites this paper
• Simulating Molecular Mechanisms of the MDM2-Mediated Regulatory Interactions: A Conformational Selection Model of the MDM2 Lid Dynamics

  2012cites this paper
• Competitive Binding between Dynamic p53 Transactivation Subdomains to Human MDM2 Protein

  2012cites this paper
• An ultrahigh affinity d-peptide antagonist Of MDM2.

  2012cites this paper
• Binding of Translationally Controlled Tumour Protein to the N-Terminal Domain of HDM2 Is Inhibited by Nutlin-3

  2012cites this paper
• Proteomic investigation of the MDM2 interactome and linear motif interactions

  2011cites this paper
• Understanding Small‐Molecule Binding to MDM2: Insights into Structural Effects of Isoindolinone Inhibitors from NMR Spectroscopy

  2011cites this paper
• NMR high resolution spectroscopy and X-ray crystallography for development of MDM2/X-p53 interaction antagonists

  2011cites this paper
• MDM2 and MDMX in cancer and development.

  2011cites this paper
• Chemical states of the N-terminal “lid” of MDM2 regulate p53 binding: Simulations reveal complexities of modulation

  2011cites this paper
• HDMX-L Is Expressed from a Functional p53-responsive Promoter in the First Intron of the HDMX Gene and Participates in an Autoregulatory Feedback Loop to Control p53 Activity*

  2010cites this paper
• The C-terminus of p53 binds the N-terminal domain of MDM2

  2010cites this paper
• Small-molecule inhibitors of MDM2 as new anticancer therapeutics.

  2010cites this paper
• Allosteric regulation of MDM2 protein

  2010cites this paper
• MDM4 binds ligands via a mechanism in which disordered regions become structured

  2010cites this paper
• The effects of phosphomimetic lid mutation on the thermostability of the N-terminal domain of MDM2.

  2010influential citation
• Targeting Mdm2 and Mdmx in cancer therapy

  2010cites this paper
• The C terminus of p 53 binds the N-terminal domain of MDM 2

  2010cites this paper
• The molecular dynamics of MDM2

  2010cites this paper
• Case Study: Inhibitors of the MDM2‐p53 Protein–Protein Interaction

  2010cites this paper
• What induces pocket openings on protein surface patches involved in protein–protein interactions?

  2009cites this paper
• Targeting Mdm2 and Mdmx in Cancer Therapy: Better Living through Medicinal Chemistry?

  2009cites this paper
• Novel concepts in MDM2 protein regulation

  2009influential citation
• Computational design and analysis of binding pockets at protein-protein interaction interfaces

  2009cites this paper
• Regulation of the E3 ubiquitin ligase activity of MDM2 by an N-terminal pseudo-substrate motif

  2009cites this paper
• Targeting the conformational transitions of MDM2 and MDMX: Insights into key residues affecting p53 recognition

  2009cites this paper
• MDM4 (MDMX) and its Transcript Variants

  2009cites this paper
• Modulation of p53 binding to MDM2: computational studies reveal important roles of Tyr100

  2009cites this paper
• Inhibitors of MDM2 and MDMX: a structural perspective.

  2009cites this paper
• Targeting the p53/MDM2 Pathway for Cancer Therapy

  2008cites this paper
• Targeting the Conformational Transitions of MDM2 and MDMX: Insights into Dissimilarities and Similarities of p53 Recognition

  2008cites this paper
• Quantitative lid dynamics of MDM2 reveals differential ligand binding modes of the p53-binding cleft.

  2008cites this paper
• THE FUNCTIONAL SIGNIFICANCE OF AN ALTERNATELY SPLICED PRODUCT OF THE HDM2 GENE

  2007cites this paper
• Gα12/13 Basally Regulates p53 through Mdm4 Expression

  2007cites this paper
• Basally Regulates p 53 through Mdm 4 Expression

  2007cites this paper
• Targeting protein-protein interactions: lessons from p53/MDM2.

  2007cites this paper
• Discovery of a novel small molecule binding site of human survivin.

  2007cites this paper
• G alpha 12/13 basally regulates p53 through Mdm4 expression.

  2007cites this paper
• Characterization of the Ubiquitin/Nedd8 E3 ligase activity of the Mdm2/MdmX complex

  2007cites this paper
• MDMX: from bench to bedside

  2007cites this paper
• Regulation of FOXO stability and activity by MDM2 E3 ligase

  2007cites this paper
• p53--a natural cancer killer: structural insights and therapeutic concepts.

  2006cites this paper
• A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network.

  2006cites this paper
• p53 – ein natürlicher Krebskiller: Einsichten in die Struktur und Therapiekonzepte

  2006cites this paper
• Structure-activity studies in a family of beta-hairpin protein epitope mimetic inhibitors of the p53-HDM2 protein-protein interaction.

  2006cites this paper
• Peptide, Peptidomimetic, and Small-molecule Antagonists of the p53–HDM2 Protein–Protein Interaction

  2006cites this paper
• Conformational changes of the p53-binding cleft of MDM2 revealed by molecular dynamics simulations.

  2006cites this paper
• Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4

  2006cites this paper
• Structure–Activity Studies in a Family of β‐Hairpin Protein Epitope Mimetic Inhibitors of the p53–HDM2 Protein–Protein Interaction

  2006cites this paper
• Structure of free MDM2 N-terminal domain reveals conformational adjustments that accompany p53-binding.

  2005cites this paper